Dr. Ho Man Chan received their Ph.D. in Molecular Biology and Biochemistry from the University of Glasgow, UK. They served as a Human Frontier Fellow at the Dana Farber Cancer Institute, Harvard Medical School. Previously, Dr. Chan held positions as a postdoc and lab head at institutions like Schering Plough and Novartis Research Institute. Currently, they are the Head of US Small Molecule Bioscience and Epigenetics in Oncology at AstraZeneca, with extensive expertise in cancer biology, drug development, and strategic leadership in cross-functional teams.
This person is not in the org chart
This person is not in any teams
This person is not in any offices